title: Discontinuation rates and timing of antimalarial drugs in primary Sjögren's syndrome.
authors.forename: Chiara
authors.initials: C
authors.lastname: Baldini
authors.forename: Chiara
authors.initials: C
authors.lastname: Notarstefano
authors.forename: Pasquale
authors.initials: P
authors.lastname: Pepe
authors.forename: Francesco
authors.initials: F
authors.lastname: Ferro
authors.forename: Nicoletta
authors.initials: N
authors.lastname: Luciano
authors.forename: Chiara
authors.initials: C
authors.lastname: Tani
authors.forename: Rosaria
authors.initials: R
authors.lastname: Talarico
authors.forename: Marta
authors.initials: M
authors.lastname: Mosca
mesh_terms: D000328:Adult; D000368:Aged; D000962:Antimalarials / Q000008:administration & dosage* / Q000009:adverse effects; D004334:Drug Administration Schedule; D057915:Drug Substitution; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D055118:Medication Adherence; D008875:Middle Aged; D012859:Sjogren's Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000962:Antimalarials; D007166:Immunosuppressive Agents